trending Market Intelligence /marketintelligence/en/news-insights/trending/yikmorrik4eafzp1ov2wiw2 content esgSubNav
In This List

Provention Bio appoints director

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Provention Bio appoints director

Provention Bio Inc. added Avery Catlin to its board.

Catlin was previously the senior vice president and CFO of Celldex Therapeutics Inc., a Hampton, N.J.-based biopharmaceutical company that develops immunotherapy technologies and other cancer-targeting biologics.

Oldwick, N.J.-based Provention Bio develops and commercializes novel therapeutics to treat and prevent immune-mediated diseases.